Artiva Biotherapeutics, Inc. (ARTV) Stock Grade

About Artiva Biotherapeutics, Inc.'s fundamentals

Artiva Biotherapeutics is a small-cap biotechnology company with a market capitalization of $104.9 million that reported zero revenue in its latest annual period, representing a complete decline from the prior year. The company posted a net loss, resulting in a net margin of 0.0%, and does not pay a dividend. With no meaningful revenue generation and negative profitability, traditional valuation metrics like P/E ratio and return on equity are not applicable, indicating the company is in a pre-revenue or early-stage development phase typical of many biotechnology firms.